Hong Kong stocks move differently | Xuanzhu Biology-B (02575.HK) rose more than 20% to break through the peak again. Xuanyue Ning entered the medical insurance directory. Two tumor products were approved intensively this year.

According to the Wisdom Financial APP, Xuanzhu Biology-B (02575.HK) rose by more than 20%, reaching a high of 93.05 Hong Kong dollars, setting a new record high for the listing. As of the time of publication, it has increased by 19.51%, trading at 92.5 Hong Kong dollars, with a turnover of 187.759 million Hong Kong dollars.